Title:
抗ミオスタチン抗体
Document Type and Number:
Japanese Patent JP2009511579
Kind Code:
A
Abstract:
Anti-myostatin antibodies are identified that are characterized as having high affinity and may be chimeric, humanized or fully human antibodies, immunoconjugates of the antibodies or antigen-binding fragments thereof. The antibodies of the invention are useful for increasing muscle mass, increasing bone density, or for the treatment of various disorders in mammalian and avian species.
More Like This:
| WO/2019/038740 | USE OF CANAKINUMAB |
| JP2005503121 | Novel polynucleotides and polypeptides of the IFNα-21 gene |
| JP2002516103 | INDUSTRIAL APPLICABILITY: Interleukin 21 and interleukin 22 |
Inventors:
Julian Davies
Brian edward jones
Andrew Iho Coritco
Pamela Gene Mitchell
Rosamund Carroll Smith
Linda O'Brien
One Long
Brian edward jones
Andrew Iho Coritco
Pamela Gene Mitchell
Rosamund Carroll Smith
Linda O'Brien
One Long
Application Number:
JP2008535569A
Publication Date:
March 19, 2009
Filing Date:
October 05, 2006
Export Citation:
Assignee:
Eli Lilly and Company
International Classes:
C07K16/24; A61K39/395; A61P1/16; A61P3/00; A61P3/04; A61P3/10; A61P7/00; A61P9/04; A61P11/00; A61P13/12; A61P19/10; A61P21/00; C12N15/09; A61P9/10; A61P19/02
Foreign References:
| WO2004037861A2 | 2004-05-06 |
Attorney, Agent or Firm:
Kyousei Tamura
Samejima Mutsumi
Masahiro Nitta
Samejima Mutsumi
Masahiro Nitta